02UR3KZ
Supplement Pulmonary Artery, Left to No Qualifier with Nonautologous Tissue Substitute, Percutaneous Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | 0 Medical and Surgical |
| Body System | 2 Heart and Great Vessels |
| Operation | U Supplement |
| Body Part | R Pulmonary Artery, Left |
| Approach | 3 Percutaneous |
| Device | K Nonautologous Tissue Substitute |
| Qualifier | Z No Qualifier |
Operation Definition
Putting in or on biological or synthetic material that physically reinforces and/or augments the function of a portion of a body part
Procedure Overview
Supplement procedures add biological or synthetic material to reinforce or enhance a portion of the heart or a great vessel without removing the existing structure. Common examples include patch repair of a septal defect, reinforcing a weakened area of the aortic wall, or placing material to strengthen a valve annulus during repair.
The goal is to shore up tissue that is present but insufficient on its own, whether because of a congenital hole, an aneurysm that has thinned the vessel wall, or a valve structure that needs extra support to function properly. Unlike a replacement, the body's own tissue stays in place and the added material works alongside it.
Patients typically encounter this term in the context of congenital defect closures, aortic aneurysm repairs, and valve repair techniques that use patches, rings, or other reinforcing materials rather than swapping out the whole valve or vessel.
Anatomy & Axis Detail
Pulmonary Artery, Left
The left pulmonary artery carries deoxygenated blood from the pulmonary trunk to the left lung and, like its right-sided counterpart, is prone to focal stenosis or hypoplasia from congenital malformation or scarring after prior shunt or banding procedures, conditions that limit blood flow and can raise right ventricular pressure over time. Supplementing the left pulmonary artery involves patch augmentation of a narrowed segment using pericardial or synthetic material to enlarge the vessel lumen and improve pulmonary perfusion, commonly performed during staged repair of complex congenital heart disease such as tetralogy of Fallot or pulmonary atresia. The vessel's course beneath the aortic arch and near the left main bronchus means surgeons must carefully plan patch length to avoid distorting adjacent structures, and postoperative imaging is often used to confirm adequate luminal caliber has been achieved.
Approach: Percutaneous
Percutaneous describes entry by needle or instrument puncture through the skin or mucous membrane to reach the site of the procedure, without cutting the tissue open or using a visualizing scope. It differs from Open in that the site itself is never exposed, and from Percutaneous Endoscopic in that no endoscope is used to see internal structures. Common examples include needle biopsies and injections.
Device: Nonautologous Tissue Substitute
Nonautologous Tissue Substitute refers to biologic material sourced from a donor or another species, such as an allograft or xenograft, used to replace a body part. It differs from Autologous Tissue Substitute by tissue origin outside the patient's own body, and from Synthetic Substitute by being biologic rather than manufactured material.
Coding & Documentation
Coders assign Supplement when the note documents that material, biological or synthetic, was added to reinforce or augment existing anatomy, such as closing a septal defect with a patch or buttressing a vessel wall. The documentation should identify the material used and confirm that native tissue was not removed and replaced, only strengthened.
The most frequent error is confusing patch closure of a defect, which is Supplement, with actual replacement of a structure, which requires taking out the original part. Another common mistake is missing that some valve repairs combine Supplement for annuloplasty ring placement with Repair for other steps done in the same operative session, each of which needs its own code.